Despite some shortcomings, we have successfully demonstrated that Hb-O measurement using the Sysmex HA is superior in eliminating lipemia interference compared to existing lipemia removal methods used worldwide, including in Croatia. The gene discussed is GSTM1; the disease is hyperlipidemia.